-
Dec 17, 2025, 9:59 am62 ptsATLANTA — The use of GLP-1 drugs to treat obesity has cause awareness of the complex medical condition to surge. But the cost of treating it also puts the health care system in a bind. Dr. Scott Kahan, director of the National Center for Weight & Wellness and a faculty member at the Johns Hopkins…
Welcome to Politomix -- the political news wire where left, right and center mix.
Politomix aggregates the day's political news on the web and your mobile device.